Literature DB >> 21656210

Effects of Schisandra sphenanthera extract on the blood concentration of tacrolimus in renal transplant recipients.

Hua-Wen Xin, Qing Li, Xiao-Chun Wu, Yan He, Ai-Rong Yu, Lei Xiong, Ying Xiong.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21656210     DOI： 10.1007/s00228-011-1075-7

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  15 in total

1.  Inhibitory effects of schisandrin A and schisandrin B on CYP3A activity.

Authors:  W L Li; H W Xin; M W Su; L Xiong
Journal:  Methods Find Exp Clin Pharmacol       Date:  2010-04

2.  Schisandrin B: a dual inhibitor of P-glycoprotein and multidrug resistance-associated protein 1.

Authors:  Meng Sun; Xiaoli Xu; Qinghua Lu; Qiangrong Pan; Xun Hu
Journal:  Cancer Lett       Date:  2006-04-18       Impact factor: 8.679

3.  Effects of Schisandra sphenanthera extract on the pharmacokinetics of tacrolimus in healthy volunteers.

Authors:  Hua-Wen Xin; Xiao-Chun Wu; Qing Li; Ai-Rong Yu; Min Zhu; Yang Shen; Dan Su; Lei Xiong
Journal:  Br J Clin Pharmacol       Date:  2007-05-15       Impact factor: 4.335

4.  Schisandrin B--a novel inhibitor of P-glycoprotein.

Authors:  Pan Qiangrong; Tao Wang; Qinghua Lu; Xun Hu
Journal:  Biochem Biophys Res Commun       Date:  2005-09-23       Impact factor: 3.575

5.  Tacrolimus oral bioavailability doubles with coadministration of ketoconazole.

Authors:  L C Floren; I Bekersky; L Z Benet; Q Mekki; D Dressler; J W Lee; J P Roberts; M F Hebert
Journal:  Clin Pharmacol Ther       Date:  1997-07       Impact factor: 6.875

6.  Effect of Schisandra sphenanthera extract on the concentration of tacrolimus in the blood of liver transplant patients.

Authors:  W Jiang; X Wang; X Xu; L Kong
Journal:  Int J Clin Pharmacol Ther       Date:  2010-03       Impact factor: 1.366

7.  Co-administration of grapefruit juice increases bioavailability of tacrolimus in liver transplant patients: a prospective study.

Authors:  Chang Liu; Ya-Fei Shang; Xu-Feng Zhang; Xiao-Gang Zhang; Bo Wang; Zheng Wu; Xue-Min Liu; Liang Yu; Feng Ma; Yi Lv
Journal:  Eur J Clin Pharmacol       Date:  2009-07-21       Impact factor: 2.953

8.  Mechanistic understanding of the different effects of Wuzhi Tablet (Schisandra sphenanthera extract) on the absorption and first-pass intestinal and hepatic metabolism of Tacrolimus (FK506).

Authors:  Xiao Ling Qin; Hui Chang Bi; Xue Ding Wang; Jia Li Li; Ying Wang; Xin Ping Xue; Xiao Chen; Chang Xi Wang; Le Jia Xu; Yi Tao Wang; Min Huang
Journal:  Int J Pharm       Date:  2010-01-25       Impact factor: 5.875

9.  Impact of St John's wort treatment on the pharmacokinetics of tacrolimus and mycophenolic acid in renal transplant patients.

Authors:  Ingrid Mai; Elke Störmer; Steffen Bauer; Hagen Krüger; Klemens Budde; Ivar Roots
Journal:  Nephrol Dial Transplant       Date:  2003-04       Impact factor: 5.992

Review 10.  Tacrolimus: review of pharmacokinetics, pharmacodynamics, and pharmacogenetics to facilitate practitioners' understanding and offer strategies for educating patients and promoting adherence.

Authors:  Michele Vicari-Christensen; Suzanne Repper; Sharon Basile; Danella Young
Journal:  Prog Transplant       Date:  2009-09       Impact factor: 1.065
View more
  9 in total

1.  Dosage Optimization Based on Population Pharmacokinetic Analysis of Tacrolimus in Chinese Patients with Nephrotic Syndrome.

Authors:  Tong Lu; Xu Zhu; Shansen Xu; Mingming Zhao; Xueshi Huang; Zhanyou Wang; Limei Zhao
Journal:  Pharm Res       Date:  2019-02-04       Impact factor: 4.200

2.  Population pharmacokinetic analysis of tacrolimus in Chinese cardiac transplant recipients.

Authors:  Yan Gong; Ming Yang; Yongfeng Sun; Jing Li; Yongning Lu; Xingang Li
Journal:  Eur J Hosp Pharm       Date:  2019-01-19

3.  Wuzhi Capsule Dosage Affects Tacrolimus Elimination in Adult Kidney Transplant Recipients, as Determined by a Population Pharmacokinetics Analysis.

Authors:  Lizhi Chen; Yunyun Yang; Xuebin Wang; Chenyu Wang; Weiwei Lin; Zheng Jiao; Zhuo Wang
Journal:  Pharmgenomics Pers Med       Date:  2021-09-03

4.  Population pharmacokinetics and pharmacogenomics of tacrolimus in Chinese children receiving a liver transplant: initial dose recommendation.

Authors:  Xiao Chen; Dong-Dong Wang; Hong Xu; Zhi-Ping Li
Journal:  Transl Pediatr       Date:  2020-10

Review 5.  Tacrolimus in preventing transplant rejection in Chinese patients--optimizing use.

Authors:  Chuan-Jiang Li; Liang Li
Journal:  Drug Des Devel Ther       Date:  2015-01-13       Impact factor: 4.162

6.  Clinical observation on the effect of Wuzhi soft capsule on FK506 concentration in membranous nephropathy patients.

Authors:  Zhu Zhang; Xiaobei Lu; Leipeng Dong; Jiwei Ma; Xiaoguang Fan
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.817

Review 7.  Research Progress on the Pharmacological Action of Schisantherin A.

Authors:  Zehao Xiao; Wen Xiao; Guilin Li
Journal:  Evid Based Complement Alternat Med       Date:  2022-02-12       Impact factor: 2.629

Review 8.  A Comprehensive Review of the Main Lignan Components of Schisandra chinensis (North Wu Wei Zi) and Schisandra sphenanthera (South Wu Wei Zi) and the Lignan-Induced Drug-Drug Interactions Based on the Inhibition of Cytochrome P450 and P-Glycoprotein Activities.

Authors:  Feng Zhang; Jianxiu Zhai; Nan Weng; Jie Gao; Jun Yin; Wansheng Chen
Journal:  Front Pharmacol       Date:  2022-03-11       Impact factor: 5.810

9.  The pharmacokinetic study of tacrolimus and Wuzhi capsule in Chinese liver transplant patients.

Authors:  Jinlong Qu; Rongrong Bian; Binguo Liu; Jiani Chen; Jingwen Zhai; Fei Teng; Wenyuan Guo; Hua Wei
Journal:  Front Pharmacol       Date:  2022-09-15       Impact factor: 5.988
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.